SCHEMBL31664093

SCHEMBL31664093

CC(C)(C)OC(=O)NCCOCCOCCCc1ccc2c(c1)c1cccnc1n2C1CCC(=O)NC1=O

nearest known ligand 0.89

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 20/20 0.89
CRBN Q96SW2 20/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21070712 1.00 DDB1 (0.89) DDB1CRBN
SCHEMBL29673951 0.99 DDB1 (0.88) DDB1CRBN
SCHEMBL21069887 0.94 DDB1 (1.00) DDB1CRBN
SCHEMBL31664207 0.94 DDB1 (1.00) DDB1CRBN
SCHEMBL23319516 0.93 DDB1 (0.88) DDB1CRBN
SCHEMBL29673963 0.92 DDB1 (1.00) DDB1CRBN
SCHEMBL29673961 0.91 DDB1 (0.87) DDB1CRBN
SCHEMBL21070579 0.90 DDB1 (0.72) DDB1CRBN
SCHEMBL21069337 0.89 DDB1 (0.80) DDB1CRBN
SCHEMBL29673954 0.89 DDB1 (0.80) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3886904-B1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2026-04-22 EP disclosed
EP-4613773-A2 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2025-09-10 EP disclosed
EP-3731869-B1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2025-07-23 EP disclosed